Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Valsartan and Amlodipine in Essential Hypertension
NCT00446524Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan, amlodipine in essential hypertension, sponsored by Novartis. Started Feb 2007; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00446524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446524.